Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shibayama

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[Correlation between an enzyme (glutathione S-transferase-pi) and effects of chemotherapy (cisplatin + etoposide)]T Arai, Y Yasuda, Y Ito, et al.
Mucosal Immunology|January 26, 2017
Cortactin deficiency causes increased RhoA/ROCK1-dependent actomyosin contractility, intestinal epithelial barrier dysfunction, and disproportionately severe DSS-induced colitisA F Citalán-Madrid, H Vargas-Robles, A García-Ponce, et al.
British Journal of Cancer|November 24, 2011
Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerE C M Zeestraten, M Maak, M Shibayama, et al.
British Journal of Cancer|January 22, 2009
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patientsJ G H van Nes, V T H B M Smit, H Putter, et al.
Translational Oncology|September 29, 2018
mTORC1 Prevents Epithelial Damage During Inflammation and Inhibits Colitis-Associated Colorectal Cancer DevelopmentI Z Gutiérrez-Martínez, J F Rubio, Z L Piedra-Quintero, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[Correlation between an enzyme (glutathione S-transferase-pi) and effects of chemotherapy (cisplatin + etoposide)]T Arai, Y Yasuda, Y Ito, et al.
Mucosal Immunology|January 26, 2017
Cortactin deficiency causes increased RhoA/ROCK1-dependent actomyosin contractility, intestinal epithelial barrier dysfunction, and disproportionately severe DSS-induced colitisA F Citalán-Madrid, H Vargas-Robles, A García-Ponce, et al.
British Journal of Cancer|November 24, 2011
Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerE C M Zeestraten, M Maak, M Shibayama, et al.
British Journal of Cancer|January 22, 2009
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patientsJ G H van Nes, V T H B M Smit, H Putter, et al.
Translational Oncology|September 29, 2018
mTORC1 Prevents Epithelial Damage During Inflammation and Inhibits Colitis-Associated Colorectal Cancer DevelopmentI Z Gutiérrez-Martínez, J F Rubio, Z L Piedra-Quintero, et al.
Pageof 12